Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer
OBJECTIVE: Patients with recurrent triple-negative breast cancer (TNBC) currently have no established treatment option other than chemotherapy. However, long-term chemotherapy is often difficult due to adverse effects. A previous study documented a 10%–30% response rate of progestins in oestrog...
Main Authors: | Xiangying Meng, Shikai Wu, Zefei Jiang, Bing Sun, Yan Ma, Xin Zhao, Lijuan Ding, Yue Wang, Tao Wang, Shaohua Zhang, Santai Song |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2013-05-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1696 |
Similar Items
-
Possible Participation of Adenine Nucleotide Translocase ANT1 in the Cytotoxic Action of Progestins, Glucocorticoids, and Diclofenac on Tumor Cells
by: Darya Ulchenko, et al.
Published: (2023-12-01) -
Megestrol acetate
by: 982 SIRIM -
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status
by: Antonella Turla, et al.
Published: (2023-09-01) -
Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells
by: Bingtao Ren, et al.
Published: (2022-10-01) -
A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia
by: Yu Liang Lim, et al.
Published: (2022-06-01)